Vet warns pet owners after common dog behaviour linked to massive parasite inside woman's body
What does the doctor say?
Where is this parasite found?
How to avoid this?
How serious can it turn for humans
A case from Tunisia has reignited an important health conversation about the hidden dangers of a common behaviour many pet owners find endearing—letting their dogs lick their faces. While millions of dog lovers share affectionate moments with their furry companions, experts are warning that this harmless gesture could, in rare cases, open the door to a potentially life-threatening parasite.Doctors recently discovered a massive cyst, double the size of a tennis ball, in the pelvis of a 26-year-old woman who was 20 weeks pregnant. The woman had endured months of abdominal pain before being rushed to the hospital, where scans revealed a hydatid cyst—a growth caused by a tapeworm infection. The condition, known as cystic echinococcosis, is caused by the Echinococcus granulosus tapeworm, most commonly transmitted through dog feces.The case was detailed in the Open Journal of Clinical & Medical Case Reports under the title "Omental hydatid cyst in pregnant women: A rare localization." The patient was from Tunisia, where the parasite is considered endemic. Researchers noted the woman's condition was rare and dangerous, especially during pregnancy, but she was treated successfully.Although the exact source of the woman's infection was not confirmed, the case has raised concerns among veterinarians, who are urging dog owners to be mindful of certain health risks. Dr. Aimee Warner, a veterinarian at pet insurance company Waggel, noted that letting dogs lick faces, particularly near the mouth or eyes, can pose hygiene concerns.While humans don't become infected by adult tapeworms living in a dog's body, they can inadvertently ingest the parasite's eggs through faecal contamination. If a dog has traces of faeces on its mouth or fur and then licks a person, there is a small but possible risk of transmission.The parasite thrives in areas where livestock are raised, and dogs may scavenge on infected animal remains, which contain larvae. Once ingested, the larvae mature into tapeworms in the dog's intestines. The eggs are then shed in the animal's stool, potentially contaminating the environment and putting humans at risk.As per the vet, regular deworming of dogs and practising good hygiene, especially after handling pets or letting them near the face, can significantly reduce the risk.The condition is extremely serious in humans, often impacting the liver, lungs, or other organs. In this particular case, the cyst formed in the omentum (a fold of tissue in the abdomen), which is an uncommon site of infection. If left untreated, hydatid cysts can grow and rupture, leading to life-threatening complications. Especially in vulnerable groups like pregnant women, early detection and surgical intervention may be the only way to avoid severe consequences.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 days ago
- Time of India
City AIIMS to get CoE status for research on sickle cell anaemia
1 2 Bhubaneswar: AIIMS Bhubaneswar is set to be accorded the status of Centre of Excellence (CoE) for management and research of sickle cell disease (SCD), announced Union tribal affairs minister Jual Oram during the World Sickle Cell Awareness Day celebration at AIIMS Bhubaneswar on Thursday. "The Centre of Excellence tag will further strengthen AIIMS Bhubaneswar's capabilities in advanced research and quality treatment in sickle cell disease," said Oram. He said the govt is committed to eradicating sickle cell anaemia by 2047. "So far, 5.79 crore people were screened across the country. Among them, 5.55 crore tested negative, 16.38 lakh were identified as carriers, and 2.1 lakh were diagnosed with the disease," he added. AIIMS Bhubaneswar currently treats more than 700 registered SCD patients, over 500 of whom are in the 0 to 19 age group. "The institute offers regular diagnostic services, treatment, and carrier screening, including for extended family members of affected persons," said AIIMS Bhubaneswar executive director Dr Ashutosh Biswas. He said the institute also provides pre-natal diagnostic services to detect conditions like Down syndrome, neural tube defects, thalassaemia, and sickle cell anaemia within the first 20 weeks of pregnancy. "If both parents are carriers, there is a 25 per cent chance that the child may be affected," he added. During this visit, Oram toured various facilities of the institute and interacted with SCD patients and their family members. He also participated in a review meeting and a scientific session focused on sickle cell disease. "Facilities at AIIMS Bhubaneswar also include exchange transfusion for patients experiencing stroke or undergoing major surgeries. Furthermore, newborn screening for genetic metabolic disorders such as congenital hypothyroidism and congenital adrenal hyperplasia is actively being carried out," said the national institute in an official statement. Bhubaneswar: AIIMS Bhubaneswar is set to be accorded the status of Centre of Excellence (CoE) for management and research of sickle cell disease (SCD), announced Union tribal affairs minister Jual Oram during the World Sickle Cell Awareness Day celebration at AIIMS Bhubaneswar on Thursday. "The Centre of Excellence tag will further strengthen AIIMS Bhubaneswar's capabilities in advanced research and quality treatment in sickle cell disease," said Oram. He said the govt is committed to eradicating sickle cell anaemia by 2047. "So far, 5.79 crore people were screened across the country. Among them, 5.55 crore tested negative, 16.38 lakh were identified as carriers, and 2.1 lakh were diagnosed with the disease," he added. AIIMS Bhubaneswar currently treats more than 700 registered SCD patients, over 500 of whom are in the 0 to 19 age group. "The institute offers regular diagnostic services, treatment, and carrier screening, including for extended family members of affected persons," said AIIMS Bhubaneswar executive director Dr Ashutosh Biswas. He said the institute also provides pre-natal diagnostic services to detect conditions like Down syndrome, neural tube defects, thalassaemia, and sickle cell anaemia within the first 20 weeks of pregnancy. "If both parents are carriers, there is a 25 per cent chance that the child may be affected," he added. During this visit, Oram toured various facilities of the institute and interacted with SCD patients and their family members. He also participated in a review meeting and a scientific session focused on sickle cell disease. "Facilities at AIIMS Bhubaneswar also include exchange transfusion for patients experiencing stroke or undergoing major surgeries. Furthermore, newborn screening for genetic metabolic disorders such as congenital hypothyroidism and congenital adrenal hyperplasia is actively being carried out," said the national institute in an official statement.
Time of India
3 days ago
- Time of India
Celina Jaitly shares her struggles with cholestasis and pregnancy complications
Actress Celina Jaitly opened up about the health challenges she faced during her twin pregnancy, shedding light on a lesser-discussed aspect of motherhood. In a heartfelt revelation on Instagram , she shared that she battled gestational diabetes, cholestasis, and other medical conditions while expecting. By speaking candidly about her experience, Celina hopes to create more awareness around high-risk pregnancies and offer support to women navigating similar journeys. Sharing a series of her photos with her kids, the 'No Entry' actress wrote, "#maternalhealth - When the Itch Could Have Taken My Babies: My Battle With Cholestasis I was born with a rare genetic gift, a tendency to hyperovulate. I had two spontaneous twin pregnancies, a trait passed down through generations of women in my family. I later learned my mother too had carried twins after my brother & me, babies she tragically lost after a fall in Ranikhet. Even my great-great-grandmother died from complications during a twin pregnancy." "Both my pregnancies were overwhelming. I had gestational diabetes and severe SPD, and in both, I developed #choleostasis of Pregnancy, a rare liver condition more common in twin pregnancies. It nearly broke me. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 마지막으로 2025년 최고의 좀비 게임을 무료로 즐기세요 경복의 바다 다운로드 Undo It starts with itching palms, soles, sleepless nights and a deep fear for your baby's safety. Cholestasis isn't "just a pregnancy itch." It's a warning from your liver that something's wrong. After my wonderful gynaecologist diagnosed me, I was referred to a hepatologist a Jordanian Dr who held my hand in a Dubai hospital and said a prayer. A man of science and faith. That moment of compassion stayed with me and reminded me of how important compassion is to a patient." Celina Jaitly also revealed that cholestasis during pregnancy is a liver condition that can have significant effects on both the baby and the mother. For the baby, it increases the risk of preterm birth, fetal distress, and the presence of meconium-stained amniotic fluid, which can lead to complications during delivery. In severe cases, if left untreated, cholestasis may even result in stillbirth. For the mother, the condition often causes intense itching-especially on the hands and feet-due to the build-up of bile acids in the bloodstream. The actress also mentioned that she was treated with Ursodeoxycholic Acid (UDCA), a medication commonly prescribed to lower bile acid levels and alleviate the discomfort associated with cholestasis.
The Hindu
4 days ago
- The Hindu
State issues GO extending Medisep for three more months
The State government's Medical Insurance Scheme for State Employees and Pensioners (Medisep), the first phase of which is drawing to a close on June 30, will be extended till September 30 with the same terms and conditions stipulated in the original Memorandum of Understanding with the insurance firm implementing the scheme. With the three-year policy period of Medisep coming to an end on June 30, 2025, the government had set up a six-member expert committee to study the scheme and recommend appropriate revisions. It sought an extension of the original contract with the Oriental insurance company for another three months till it can scrutinise the expert committee's recommendations and float the new tender for the revised scheme The government order (GO) issued by the Finance department extending Medisep for three more months says that the premium charged for the extended period of the scheme will be ₹1,593, including GST, per family for the entire three months period for the existing number of families covered by Medisep. Slightly higher Though this works out to ₹531/month, slightly higher than the current actual premium of ₹472 per month, the government has decided to meet this additional expense from the balance in the corpus fund so that neither the beneficiaries nor the State exchequer will incur any additional payment. Though the insurance company had earlier taken the stand that while extending the contract, it can provide insurance cover to existing families only for whatever balance sum insured remains as on June 30, the State government re-negotiated with the insurance company Thus, families who have already exhausted their sum insured or those whose balance sum insured is less than ₹75,000 as on June 30 will also get a basic insurance coverage of ₹75,000 for the next three months. This has been fixed in proportion to the additional premium paid by the government per family for the extended period. The scheme will provide cashless treatment as well as the benefit of the package to the beneficiaries with the same terms and conditions of the existing Medisep scheme till September 30. Medisep, launched in July 2022, offered a basic insurance cover of ₹3 lakh, at a monthly premium of around ₹500. It covers over 30 lakh individuals, including some 5.45 lakh government employees, 5.89 lakh pensioners and their dependents. Enhanced coverage The expert committee constituted by the government to revise the terms of Medisep had recommended an enhanced basic insurance coverage from ₹3 lakh to ₹5 lakh, based on the framework of the Health Benefits Package (HBP) 2022 formulated by the National Health Authority. It had also recommended that the Medisep policy period be reduced to two years and that the scheme should be extended to employees and pensioners in public sector undertakings, Corporations, autonomous, statutory bodies and the cooperative sector, so that the increase in the overall risk pool can rein in the premium.
